Merck & Co., Inc.MRKNYSE
LOADING
|||
Cost of Revenue Over Time
Profitability in line with historical norms
Left:
||||
Direct costs attributable to producing goods sold
Latest
$15.19B
Near historical average
Average (9y)
$14.34B
Historical baseline
Range
High:$17.41B
Low:$12.02B
CAGR
+0.2%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $15.19B | -5.8% |
| 2023 | $16.13B | -7.4% |
| 2022 | $17.41B | +27.8% |
| 2021 | $13.63B | +0.1% |
| 2020 | $13.62B | +13.3% |
| 2019 | $12.02B | -11.1% |
| 2018 | $13.51B | +4.6% |
| 2017 | $12.91B | -8.0% |
| 2016 | $14.03B | -6.1% |
| 2015 | $14.93B | - |